Kuehn Law Encourages Investors of CG Oncology, Inc. to Contact Law Firm

Kuehn Law is investigating whether officers and directors of CG Oncology, Inc. breached fiduciary duties to shareholders through potential self-dealing. Long-term shareholders may be entitled to damages and corporate governance reforms. The law firm is seeking shareholders to participate in the investigation at no cost.